Crinetics Pharmaceuticals Inc (FRA:6Z4)
€ 70.9 -0.88 (-1.23%) Market Cap: 7.79 Bil Enterprise Value: 6.70 Bil PE Ratio: 0 PB Ratio: 6.90 GF Score: 50/100

Crinetics Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript

Mar 04, 2026 / 06:50PM GMT
Release Date Price: €33.6
Tyler Van Buren
Cowen and Company LLC - Analyst

Good afternoon, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowen.

Thank you very much for joining TD Cowen's 46th Annual Healthcare Conference. For next session, very excited to have a hybrid presentation and fireside with Crinetics. And it's my pleasure to introduce Tobin Schilke, the Chief Financial Officer; and Alan Krasner, the Chief Endocrinologist.

Tobin and Alan, thank you so much for joining me.

Tobin Schilke
Crinetics Pharmaceuticals Inc - Chief Financial Officer

Thank you, Tyler. It's great to be here at the, used to be just the Cowen, but now it's the TD Cowen conference, and it's, I've been coming for almost a decade now, and it's always a pleasure, and you're a terrific analyst, Tyler, and I really appreciated working with you the last year I've been at Crinetics. Thanks very much. We're going to be making forward-looking statements. Please read them as you do your diligence about this investment opportunity.

So Crinetics was founded in 2008 by three

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot